# Clinical Trials of Multivalent Opioid Vaccine Components

> **NCT04458545** · PHASE1,PHASE2 · RECRUITING · sponsor: **New York State Psychiatric Institute** · enrollment: 45 (estimated)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **BIOLOGICAL:** Oxy(Gly)4-sKLH vaccine - Low Dose
- **BIOLOGICAL:** Oxy(Gly)4-sKLH vaccine - High Dose
- **BIOLOGICAL:** Placebo Oxy(Gly)4-sKLH vaccine

## Key facts

- **NCT ID:** NCT04458545
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-08
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04458545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04458545, "Clinical Trials of Multivalent Opioid Vaccine Components". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04458545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*